Cargando…
AMI, an Indazole Derivative, Improves Parkinson’s Disease by Inhibiting Tau Phosphorylation
Dopaminergic neuronal loss is the main pathological character of Parkinson’s disease (PD). Abnormal tau hyperphosphorylation will lead to dopaminergic neuronal loss. An indazole derivative 6-amino-1-methyl-indazole (AMI) successfully synthesized to inhibit tau hyperphosphorylation may exert a neurop...
Autores principales: | Mao, Zhang, Wen-ting, Zhu, Hai-tao, Wang, Hui, Yu, Shi-yi, Lan, Jiang-ping, Xu, Wen-ya, Wang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710523/ https://www.ncbi.nlm.nih.gov/pubmed/33328879 http://dx.doi.org/10.3389/fnmol.2020.00165 |
Ejemplares similares
-
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018) -
The Evolution of Tau Phosphorylation and Interactions
por: Trushina, Nataliya I., et al.
Publicado: (2019) -
The Importance of Tau Phosphorylation for Neurodegenerative Diseases
por: Noble, Wendy, et al.
Publicado: (2013) -
Tau expression and phosphorylation in enteroendocrine cells
por: Chapelet, Guillaume, et al.
Publicado: (2023) -
Structural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
por: Lasorsa, Alessia, et al.
Publicado: (2018)